Sponsor: Horizon DiscoveryIn this GEN webinar, sponsored by Horizon Discovery, we will provide a field overview of how iPSCs, coupled with genome editing, hold the potential to expand our understanding of human diseases further, and facilitate the development of new therapies.
Sponsor: TriLink BioTechnologiesDuring this presentation, which is part of TriLink BioTechnologies gene editing and cell therapy webinar series, Dr. Gaudelli will discuss how her group has transformed off-the-shelf base editors from a technology developed in academia to a promising therapeutic tool through engineering, screening, and directed evolution.
Sponsor: PerkinElmerIn this recorded GEN Live event, sponsored by PerkinElmer, we discussed the state of gene therapy, the rise of AAV, and the safety issues that need to be addressed going forward.
Sponsor: LonzaIn this GEN webinar, sponsored by Lonza, we will hear about a high-throughput platform for CRISPR-Cas9 gene editing in primary human cells for the robust functional interrogation of complex biological processes and disease states. We also learn about the clinically relevant scale of gene-editing, platforms, and approaches, process development considerations for bringing these gene-edited therapies to the clinic.
Sponsor: Wyatt TechnologyIn this GEN webinar, sponsored by Wyatt Technology, we will discuss how dynamic light scattering (DLS) and multi-angle light scattering combined with size exclusion chromatography (SEC-MALS) or field-flow fractionation (FFF-MALS) characterize AAV, LV, and other gene delivery vectors.
Sponsor: Hera BioLabsIn this GEN webinar, sponsored by Hera BioLabs, we will hear from scientific experts about the design and implementation considerations for Cas-CLOVER, as well as validation data for the use of this gene-editing system in human and CHO cells, as well as yeast and plants.
Sponsor: TecanJoin us for Episode 4 of GEN Live, sponsored by Tecan. In this live zoom event we discuss the state of vaccine development for COVID-19. We evaluate the front-runners, explore the potential of RNA vaccines, ponder the challenges of manufacturing, and tackle questions about herd immunity.
Sponsor: GenScript ProBioIn this GEN webinar, we will hear how GenScript ProBio aids the biopharma industry as it continues to develop and optimize processes for GMP plasmids, lenti, and AAV viral vector manufacturing.
Sponsor: Absorption SystemsIn this GEN Keynote webinar, Dr. Peter Marks, director of the Center for Biologics Evaluation and Research (CBER) at the FDA, will share how CBER is providing oversight to organizations during the critical developmental and manufacturing stages for biological products, as well as throughout the product life cycle.
Sponsor: TriLink BiotechnologiesIn this GEN webinar, Dr. Wen Xue will present a modular delivery strategy for homology-directed repair by combining lipid nanoparticle delivery of Cas9 mRNA with adeno-associated viruses (AAV) encoding a sgRNA and a repair template.